Maria Gabriela Raso

Dr. Maria Gabriela Raso

University of Texas MD Anderson Cancer Center
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
DPDavid H. Peng
David H. Peng
BRBertha Leticia Rodriguez
Bertha Leticia Rodriguez
LDLixia Diao
Lixia Diao
LCLimo Chen
Limo Chen
JWJing Wang
Jing Wang
DGDon L. Gibbons
Don L. Gibbons
Tumor extracellular matrix has been associated with drug resistance and immune suppression. Here, proteomic and RNA profiling reveal increased collagen levels in lung tumors resistant to PD-1/PD-L1 blockade. Additionally, elevated collagen correlates with decreased total CD8+T cells and increased exhausted CD8+T cell subpopulations in murine and human lung tumors. Collagen-induced T cell exhaustion occurs through the receptor LAIR1, which is upregulated following CD18 interaction with collagen, and induces T cell exhaustion through SHP-1. Reduction in tumor collagen deposition through LOXL2 suppression increases T cell infiltration, diminishes exhausted T cells, and abrogates resistance to anti-PD-L1. Abrogating LAIR1 immunosuppression through LAIR2 overexpression or SHP-1 inhibition sensitizes resistant lung tumors to anti-PD-1. Clinically, increased collagen, LAIR1, and TIM-3 expression in melanoma patients treated with PD-1 blockade predict poorer survival and response. Our study identifies collagen and LAIR1 as potential markers for immunotherapy resistance and validates multiple promising therapeutic combinations.

1 May 2012 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
PDF file
APApar Pataer
Apar Pataer
NKNeda Kalhor
Neda Kalhor
ACArlene M. Correa
Arlene M. Correa
Maria Gabriela RasoMaria Gabriela Raso
Maria Gabriela Raso
JEJeremy J. Erasmus
Jeremy J. Erasmus
SSStephen G. Swisher
Stephen G. Swisher

1 April 2021 in Laboratory Investigation
Verified
Journal Article
Closed access
DADi Ai
Di Ai
JYJun Yao
Jun Yao
FYFei Yang
Fei Yang
LHLei Huo
Lei Huo
HCHui Chen
Hui Chen
QDQingqing Ding
Qingqing Ding

26 July 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
CBCaterina Bartolacci
Caterina Bartolacci
CACristina Andreani
Cristina Andreani
GVGonçalo Vale
Gonçalo Vale
SBStefano Berto
Stefano Berto
MMMargherita Melegari
Margherita Melegari
PSPier Paolo Scaglioni
Pier Paolo Scaglioni
Mutant KRAS (KM), the most common oncogene in lung cancer (LC), regulates fatty acid (FA) metabolism. However, the role of FA in LC tumorigenesis is still not sufficiently characterized. Here, we show that KMLC has a specific lipid profile, with high triacylglycerides and phosphatidylcholines (PC). We demonstrate that FASN, the rate-limiting enzyme in FA synthesis, while being dispensable in EGFR-mutant or wild-type KRAS LC, is required for the viability of KMLC cells. Integrating lipidomic, transcriptomic and functional analyses, we demonstrate that FASN provides saturated and monounsaturated FA to the Lands cycle, the process remodeling oxidized phospholipids, such as PC. Accordingly, blocking either FASN or the Lands cycle in KMLC, promotes ferroptosis, a reactive oxygen species (ROS)- and iron-dependent cell death, characterized by the intracellular accumulation of oxidation-prone PC. Our work indicates that KM dictates a dependency on newly synthesized FA to escape ferroptosis, establishing a targetable vulnerability in KMLC.

16 February 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Maria Gabriela RasoMaria Gabriela Raso
Maria Gabriela Raso
NBNeus Bota-Rabassedas
Neus Bota-Rabassedas
IWIgnacio I. Wistuba
Ignacio I. Wistuba
Lung cancer is consistently the leading cause of cancer-related death worldwide, and it ranks as the second most frequent type of new cancer cases diagnosed in the United States, both in males and females. One subtype of lung cancer, small cell lung carcinoma (SCLC), is an aggressive, poorly differentiated, and high-grade neuroendocrine carcinoma that accounts for 13% of all lung carcinomas. SCLC is the most frequent neuroendocrine lung tumor, and it is commonly presented as an advanced stage disease in heavy smokers. Due to its clinical presentation, it is typically diagnosed in small biopsies or cytology specimens, with routine immunostaining only. However, immunohistochemistry markers are extremely valuable in demonstrating neuroendocrine features of SCLC and supporting its differential diagnosis. The 2015 WHO classification grouped all pulmonary neuroendocrine carcinomas in one category and maintained the SCLC combined variant that was previously recognized. In this review, we explore multiple aspects of the pathologic features of this entity, as well as clinically relevant immunohistochemistry markers expression and its molecular characteristics. In addition, we will focus on characteristics of the tumor microenvironment, and the latest pathogenesis findings to better understand the new therapeutic options in the current era of personalized therapy.

15 February 2008 in Cancer Research
Verified
Journal Article
Open access
PDF file
KIKentaro Iwanaga
Kentaro Iwanaga
YYYanan Yang
Yanan Yang
Maria Gabriela RasoMaria Gabriela Raso
Maria Gabriela Raso
LMLijiang Ma
Lijiang Ma
AHAmy E. Hanna
Amy E. Hanna
JKJonathan M. Kurie
Jonathan M. Kurie
Phosphatase and tensin homologue deleted from chromosome 10 (Pten) is expressed aberrantly in non–small cell lung cancer cells, but the role of Pten in lung neoplasia has not been fully elucidated. In this study, we used a genetic approach to inactivate Pten in the bronchial epithelium of mice. Although, by itself, Pten inactivation had no discernible effect on bronchial epithelial histology, it accelerated lung tumorigenesis initiated by oncogenic K-ras, causing more rapid lethality than that induced by oncogenic K-ras alone (8 weeks versus 24 weeks of median duration of survival, respectively). Lung tumors arose in K-ras mutant, Pten-deficient mice that rapidly obstructed bronchial lumina and replaced alveolar spaces. Relative to K-ras mutant tumors, the K-ras mutant, Pten-deficient tumors exhibited more advanced histologic severity and more prominent inflammation and vascularity. Thus, Pten inactivation cooperated with oncogenic K-ras in promoting lung tumorigenesis. [Cancer Res 2008;68(4):1119–27]